← Back to headlines
Herantis Pharma Selected For Horizon 2025 Grant
Herantis Pharma has been selected to receive a Horizon 2025 Grant, supporting its research and development efforts.
19 Feb, 15:36 — 19 Feb, 15:36
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
Investment Outlook: Dividend Aristocrats Poised for 2026 Rebound
19m ago
Stock Market Today, Feb. 20: CoreWeave Falls After Blue Owl Data Center Financing Failure Raises Funding Concerns
59m ago
Why CoreWeave Was Plunging To End the Week Today
59m ago
Costco Price Target Raised by Evercore ISI and Citi After Q2 Beat
59m ago